Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
about
Sickle cell disease in childrenInduction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathwayCenter for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy community.Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.
P2860
Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapy for beta-globinopathie ...... uccessful and safe correction.
@en
Therapy for beta-globinopathie ...... uccessful and safe correction.
@nl
type
label
Therapy for beta-globinopathie ...... uccessful and safe correction.
@en
Therapy for beta-globinopathie ...... uccessful and safe correction.
@nl
prefLabel
Therapy for beta-globinopathie ...... uccessful and safe correction.
@en
Therapy for beta-globinopathie ...... uccessful and safe correction.
@nl
P2860
P1476
Therapy for beta-globinopathie ...... uccessful and safe correction.
@en
P2093
Ajay Perumbeti
Punam Malik
P2860
P356
10.1111/J.1749-6632.2010.05584.X
P407
P577
2010-08-01T00:00:00Z